BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 33503992)

  • 1. Genetic Delivery and Gene Therapy in Pulmonary Hypertension.
    Rai N; Shihan M; Seeger W; Schermuly RT; Novoyatleva T
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.
    McMurtry MS; Archer SL; Altieri DC; Bonnet S; Haromy A; Harry G; Bonnet S; Puttagunta L; Michelakis ED
    J Clin Invest; 2005 Jun; 115(6):1479-91. PubMed ID: 15931388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary hypertension: microRNAs in pathogenesis, diagnosis and therapy].
    Huber LC; Leuenberger C; Kohler M; Brock M
    Pneumologie; 2014 Jun; 68(6):386-93. PubMed ID: 24715431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension.
    Reynolds AM; Holmes MD; Danilov SM; Reynolds PN
    Eur Respir J; 2012 Feb; 39(2):329-43. PubMed ID: 21737550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model.
    Aguero J; Ishikawa K; Hadri L; Santos-Gallego CG; Fish KM; Kohlbrenner E; Hammoudi N; Kho C; Lee A; Ibáñez B; García-Alvarez A; Zsebo K; Maron BA; Plataki M; Fuster V; Leopold JA; Hajjar RJ
    J Am Coll Cardiol; 2016 May; 67(17):2032-46. PubMed ID: 27126531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
    Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
    Hong Z; Chen KH; DasGupta A; Potus F; Dunham-Snary K; Bonnet S; Tian L; Fu J; Breuils-Bonnet S; Provencher S; Wu D; Mewburn J; Ormiston ML; Archer SL
    Am J Respir Crit Care Med; 2017 Feb; 195(4):515-529. PubMed ID: 27648837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis.
    Barman SA; Li X; Haigh S; Kondrikov D; Mahboubi K; Bordan Z; Stepp DW; Zhou J; Wang Y; Weintraub DS; Traber P; Snider W; Jonigk D; Sullivan J; Crislip GR; Butcher JT; Thompson J; Su Y; Chen F; Fulton DJR
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L784-L797. PubMed ID: 30724100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.
    Campbell AI; Zhao Y; Sandhu R; Stewart DJ
    Circulation; 2001 Oct; 104(18):2242-8. PubMed ID: 11684638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats.
    Pozeg ZI; Michelakis ED; McMurtry MS; Thébaud B; Wu XC; Dyck JR; Hashimoto K; Wang S; Moudgil R; Harry G; Sultanian R; Koshal A; Archer SL
    Circulation; 2003 Apr; 107(15):2037-44. PubMed ID: 12695303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cells Expressing eNOS and a Cav1 Mutant Inhibit Vascular Smooth Muscle Cell Proliferation in a Rat Model of Pulmonary Hypertension.
    Chen H; Yang H; Yue H; Strappe PM; Xia P; Pan L; Zhang Y; Chai S; Chen S; Ma L; Wang L
    Heart Lung Circ; 2017 May; 26(5):509-518. PubMed ID: 27771236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension.
    Kim JD; Lee A; Choi J; Park Y; Kang H; Chang W; Lee MS; Kim J
    Exp Mol Med; 2015 Jul; 47(7):e175. PubMed ID: 26228095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary arterial hypertension and microRNAs--an ever-growing partnership.
    Wang Y; Xue XY; Liu YX; Wang KF; Zang XF; Wang J; Wang PL; Zhang J; Pan L; Zhang SY; Wang JX
    Arch Med Res; 2013 Oct; 44(7):483-7. PubMed ID: 24051036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling.
    Xiao Y; Gong D; Wang W
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2733-9. PubMed ID: 24072692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for pulmonary hypertension: prospects and challenges.
    Reynolds PN
    Expert Opin Biol Ther; 2011 Feb; 11(2):133-43. PubMed ID: 21219232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adventitial Fibroblast Nox4 Expression and ROS Signaling in Pulmonary Arterial Hypertension.
    Barman SA; Fulton D
    Adv Exp Med Biol; 2017; 967():1-11. PubMed ID: 29047077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.